IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 68 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $256,000 | -13.5% | 194,217 | +20.9% | 0.00% | – |
Q1 2018 | $296,000 | -12.7% | 160,600 | 0.0% | 0.00% | – |
Q4 2017 | $339,000 | -5.3% | 160,600 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $358,000 | +29.7% | 160,600 | 0.0% | 0.00% | – |
Q2 2017 | $276,000 | -30.5% | 160,600 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $397,000 | +58.2% | 160,600 | -4.2% | 0.00% | – |
Q4 2016 | $251,000 | -41.5% | 167,600 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $429,000 | +56.6% | 167,600 | -6.4% | 0.00% | – |
Q2 2016 | $274,000 | -25.1% | 179,100 | -3.0% | 0.00% | -100.0% |
Q1 2016 | $366,000 | -39.5% | 184,700 | -5.7% | 0.00% | 0.0% |
Q4 2015 | $605,000 | -7.8% | 195,900 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $656,000 | -9.8% | 195,900 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $727,000 | +3.6% | 195,900 | +34.3% | 0.00% | 0.0% |
Q1 2015 | $702,000 | 0.0% | 145,900 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $702,000 | +110.2% | 145,900 | 0.0% | 0.00% | – |
Q3 2014 | $334,000 | -21.0% | 145,900 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $423,000 | +5.0% | 145,900 | +36.4% | 0.00% | 0.0% |
Q1 2014 | $403,000 | +1.0% | 107,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $399,000 | +114.5% | 107,000 | 0.0% | 0.00% | – |
Q3 2013 | $186,000 | +165.7% | 107,000 | 0.0% | 0.00% | – |
Q2 2013 | $70,000 | – | 107,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 445,558 | $3,970,000 | 0.46% |
MYCIO WEALTH PARTNERS, LLC | 40,815 | $364,000 | 0.04% |
LAU ASSOCIATES LLC | 4,539 | $52,000 | 0.03% |